Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Bribery for passing...

    Bribery for passing failed Dobutamine Injections: Pharma Company Owner, CDSCO drug inspector Arrested

    Farhat NasimWritten by Farhat Nasim Published On 2019-08-17T15:02:59+05:30  |  Updated On 17 Aug 2019 3:02 PM IST
    Bribery for passing failed Dobutamine Injections: Pharma Company Owner, CDSCO drug inspector Arrested

    As per recent media accounts, the CDSCO inspector allegedly demanded a bribe of Rs 1.5 lakh in lieu of overlooking the deficits and approving a cardiac drug Dobutamine which already failed quality test conducted by the authority.


    New Delhi: In a shocking incident, the Central Drug Standard Control Organisation (CDSCO) drug inspector has been arrested under bribery charges by the Central Bureau of Investigation (CBI).


    As per recent media accounts, the drug inspector allegedly demanded a bribe of Rs 1.5 lakh in lieu of overlooking the deficits and approving a cardiac drug Dobutamine which already failed quality test conducted by the authority.


    Dobutamine is commonly used in cardiac surgery to give a boost to cardiac functioning to treat acute heart failure.


    The matter came to light after the agency received a tip-off about the alleged deal between the CDSCO officials working under the Ministry of Health and Family Welfare and others including the Managing Director, Director and Chief Pharmacist of Kwality Pharmaceuticals and a driver.


    Also Read: Six bodies registered with CDSCO to audit medical device manufacturing sites as per new MD Rules


    The conspiracy was made after the Amritsar-based pharma company's dobutamine injections failed to clear test conducted by the CDSCO officials. The samples of the injections sent could not meet the standard and a report was sent to the pharma firm.


    The MD of Kwality Pharma challenged the report and sent another set of injections to the test laboratories.


    Meanwhile, the company's pharmacist in assistance with the director of the pharma company allegedly reached out to the CDSCO official and sought to "settle the matter” on July 18.


    Also Read: Track and trace codes For Pharma APIs: Ministry issues gazette, CDSCO issues notice


    The CDSCO inspector allegedly assured officials of Kwality pharma to settle the matter while discussing the bribe amount in exchange of a favourable decision. The drug inspector had reportedly pointed out the involvement of the senior officials of the CDSCO in the scam.


    Later, the CDSCO official informed the pharma company that he would need to visit the company’s premises for an investigation as the second batch of samples had also failed to clear the test.


    An FIR has been registered against the drug inspector and others from Kwality Pharma who have been booked. They were in CBI custody for four days as the CBI investigation continues in the case, report TH.


    It is learnt that localities of the accused in Amritsar and Delhi were also raided.

    Amritsar pharma cocardiact drugCBI)CDSCOcdsco inspectorCentral Bureau of InvestigationCentral Drug Standard Control Organisationdobutaminedobutamine injectiondobutamine sample testdrug inspectordrug sampledrug testheart drugKwality Pharmapharmapharma companypharma newspharma news india
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok